Anti-Apolipoprotein A V/APOA5 antibody [2G1H11, 1F1E8]
5
(1 Review)
|
(2 Publications)
Mouse Monoclonal Apolipoprotein A V/APOA5 antibody. Suitable for WB, sELISA and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human APOA5.
View Alternative Names
RAP3, UNQ411/PRO773, APOA5, Apolipoprotein A-V, Apo-AV, ApoA-V, Apolipoprotein A5, Regeneration-associated protein 3
- sELISA
Unknown
Sandwich ELISA - Anti-Apolipoprotein A V/APOA5 antibody [2G1H11, 1F1E8] (AB115772)
Sandwich ELISA using antibody pair to detect human Apolipoprotein A V/APOA5 protein.
- WB
Unknown
Western blot - Anti-Apolipoprotein A V/APOA5 antibody [2G1H11, 1F1E8] (AB115772)
All lanes:
Western blot - Anti-Apolipoprotein A V/APOA5 antibody [2G1H11, 1F1E8] (ab115772) at 1/500 dilution
All lanes:
Human serum
Predicted band size: 41 kDa
false
- WB
Unknown
Western blot - Anti-Apolipoprotein A V/APOA5 antibody [2G1H11, 1F1E8] (AB115772)
All lanes:
Western blot - Anti-Apolipoprotein A V/APOA5 antibody [2G1H11, 1F1E8] (ab115772) at 1/500 dilution
All lanes:
Human recombinant Apolipoprotein A V/APOA5 protein
Predicted band size: 41 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
APOA5 influences triglyceride metabolism and is part of the HDL particle complex. It interacts directly with lipoprotein lipase to promote the hydrolysis of triglycerides into free fatty acids. This hydrolytic action aids in reducing triglyceride levels in the plasma. APOA5 also indirectly influences very-low-density lipoprotein (VLDL) metabolism reinforcing its role in lipid regulation.
Pathways
APOA5 integrates into the lipoprotein metabolic pathway and the PPAR signaling pathway. In the lipoprotein metabolic pathway APOA5 works with proteins like APOC3 to influence triglyceride homeostasis. This protein is modulated by PPAR-alpha helping control lipid metabolism and energy homeostasis. Its role in these pathways highlights its impact on triglyceride-rich lipoprotein metabolism positioning it as an important player in maintaining lipid balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular medicine 51: PubMed37026514
2023
Applications
Unspecified application
Species
Unspecified reactive species
Computational and structural biotechnology journal 20:4717-4732 PubMed36147669
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com